EyePoint (EYPT) Exchange Rate Effect (2010 - 2019)
EyePoint (EYPT) posted Exchange Rate Effect of $1000.0 for Q4 2019, up 200.0% sequentially from -$1000.0 in Q4 2018, and up 200.0% YoY from $333.33 in Q4 2018.
EyePoint (EYPT) Exchange Rate Effect (2010 - 2019) Analysis & Trends
EyePoint has reported Exchange Rate Effect for 10 years, with the latest figure at $1000.0 in Q4 2019.
- Quarterly Exchange Rate Effect rose 200.0% year-over-year to $1000.0 in Q4 2019, while the trailing twelve-month figure through Jun 2020 was $1000.0 (up 133.33% YoY) and the FY2019 annual result came in at $1000.0, changed N/A from the prior year.
- Exchange Rate Effect rose to $1000.0 in Q4 2019 per EYPT's latest filing, from -$1000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $6000.0 in Q2 2017 and troughed at -$8000.0 in Q2 2016.
- A 5-year average of -$1312.5 and a median of -$2000.0 in 2016 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2015 and 2016: Exchange Rate Effect jumped 600.0% in 2015, then plunged 260.0% in 2016.
- Over 5 years, Exchange Rate Effect stood at -$5000.0 in 2015, then soared by 60.0% to -$2000.0 in 2016, then soared by 400.0% to $6000.0 in 2017, then slumped by 116.67% to -$1000.0 in 2018, then surged by 200.0% to $1000.0 in 2019.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $1000.0, -$1000.0, and -$2000.0 for Q4 2019, Q4 2018, and Q3 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | EyePoint | 1.25 Bn | 1.07 Bn | 507,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Dec 31, 2018 | -1,000.00 |
| Sep 30, 2018 | -2,000.00 |
| Sep 30, 2018 | -2,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Dec 31, 2017 | 6,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Jun 30, 2017 | 6,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -2,000.00 |
| Dec 31, 2016 | -2,000.00 |
| Sep 30, 2016 | -8,000.00 |
| Sep 30, 2016 | -8,000.00 |